Self-controlled case series design in vaccine safety: a systematic review

References

• Bonhoeffer J, Black S, Izurieta H, et al. Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe. Biologicals. 2012 ;40(5):393–397.
   PubMed Web of Science ®Google Scholar
• Nordmann S, Biard L, Ravaud P, et al. Case-only designs in pharmacoepidemiology: a systematic review. PLoS One. 2012;7(11):e49444.
   PubMed Web of Science ®Google Scholar
• Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ. 2016;354:i4515.
   PubMed Web of Science ®Google Scholar
• Gault N, Castañeda-Sanabria J, De Rycke Y, et al. Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review. BMC Med Res Methodol. 2017;17(1):25.
   PubMedGoogle Scholar
• Weldeselassie Y, Whitaker H, Farrington C. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice. Epidemiol Infect. 2011;139(12):1805–1817.
   PubMed Web of Science ®Google Scholar
• Farrington P, Whitaker H, Ghebremichael-Weldeselassie Y. Self-controlled case series studies: a modelling guide with R. London: Chapman & Hall/CRC Press. 2018.
   Google Scholar
• Langan SM, Schmidt SA, Wing K, et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ. 2018;363:k3532.
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Smeeth L, Guttmann A, et al. The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Hawken S, Potter BK, Little J, et al. The use of relative incidence ratios in self-controlled case series studies: an overview. BMC Med Res Methodol. 2016;16(1):126.
   PubMedGoogle Scholar
• Nie X, Zhang Y, Wu Z, et al. Evaluation of reporting quality for observational studies using routinely collected health data in pharmacovigilance. Expert Opin Drug Saf. 2018;17(7):661–668.
   PubMed Web of Science ®Google Scholar
• Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995;345(8949):567–569.
   PubMed Web of Science ®Google Scholar
• Andrews N, Stowe J, Miller E, et al. A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark. Vaccine. 2012;30(19):3042–3046.
   PubMed Web of Science ®Google Scholar
• Kramarz P, DeStefano F, Gargiullo PM, et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink team. Arch Fam Med. 2000;9(7):617–623.
   PubMedGoogle Scholar
• Ktm S-V, de Ridder MA, Kemmeren JM, et al. Examining a possible association between human papilloma virus (HPV) vaccination and migraine: results of a cohort study in the Netherlands. Eur J Pediatr. 2015;174(5):641–649.
   PubMed Web of Science ®Google Scholar
• Hviid A, Svanstrom H, Scheller NM, et al. Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases. J Intern Med. 2018;283(2):154–165.
   PubMed Web of Science ®Google Scholar
• Huang WT, Gargiullo PM, Broder KR, et al. Lack of association between acellular pertussis vaccine and seizures in early childhood. Pediatrics. 2010;126(2):263–269.
   PubMed Web of Science ®Google Scholar
• Scheller NM, Svanstrom H, Pasternak B, et al. Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system. JAMA. 2015;313(1):54–61.
   PubMed Web of Science ®Google Scholar
• Sun Y, Christensen J, Hviid A, et al. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B. JAMA. 2012;307(8):823–831.
   PubMed Web of Science ®Google Scholar
• Ghaderi S, Gunnes N, Bakken IJ, et al. Risk of Guillain-Barre syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study. Eur J Epidemiol. 2016;31(1):67–72.
   PubMed Web of Science ®Google Scholar
• Schurink-Van’t Klooster TM, Kemmeren JM, NATvd M, et al. No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls. Vaccine. 2018;36(45):6796–6802.
   PubMed Web of Science ®Google Scholar
• Thomsen RW, Öztürk B, Pedersen L, et al. Hospital records of pain, fatigue, or circulatory symptoms in girls exposed to human papillomavirus vaccination: cohort, self-controlled case series, and population time trend studies. Am J Epidemiol. 2020 ;189(4):277–285.
   PubMed Web of Science ®Google Scholar
• Kramarz P, DeStefano F, Gargiullo PM, et al. Does influenza vaccination prevent asthma exacerbations in children?. J Paediatr. 2001;138(3):306–310.
   PubMed Web of Science ®Google Scholar
• Tseng HF, Sy LS, Qian L, et al. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clinl Infect Dis. 2013;56(3):315–321.
   PubMed Web of Science ®Google Scholar
• Payne DC, Aranas A, McNeil MM, et al. Concurrent vaccinations and U.S. military hospitalizations. Ann Epidemiol. 2007;17(9):697–703.
   PubMed Web of Science ®Google Scholar
• Dourado I, Cunha S, Teixeira MG, et al. Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs. Am J Epidemiol. 2000;151(5):524–530.
   PubMed Web of Science ®Google Scholar
• Taylor B, Andrews N, Stowe J, et al. No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome [Article]. Arch Dis Child. 2007;92(10):887–889.
   PubMed Web of Science ®Google Scholar
• Groome MJ, Tate JE, Arnold M, et al. Evaluation of intussusception after oral monovalent rotavirus vaccination in South Africa. Clin Infect Dis. 2020;70(8):1606–1612.
   PubMed Web of Science ®Google Scholar
• Hocine MN, Farrington CP, Touze E, et al. Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method. Vaccine. 2007;25(31):5938–5943.
   PubMed Web of Science ®Google Scholar
• Carlin JB, Macartney KK, Lee KJ, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia’s National Immunization Program. Clin Infect Dis. 2013;57(10):1427–1434.
   PubMed Web of Science ®Google Scholar
• Galeotti F, Massari M, D’Alessandro R, et al. Risk of Guillain-Barre syndrome after 2010-2011 influenza vaccination. Eur J Epidemiol. 2013;28(5):433–444.
   PubMed Web of Science ®Google Scholar
• Huang WT, Chen RT, Hsu YC, et al. Vaccination and unexplained sudden death risk in Taiwanese infants. Pharmacoepidemiol Drug Saf. 2017 ;26(1):17–25.
   PubMed Web of Science ®Google Scholar
• Patel MM, Lopez-Collada VR, Bulhoes MM, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011;364(24):2283–2292.
   PubMed Web of Science ®Google Scholar
• Reddy SN, Nair NP, Tate JE, et al. Intussusception after rotavirus vaccine introduction in India [Article]. N Engl J Med. 2020;383(20):1932–1940.
   PubMed Web of Science ®Google Scholar
• Mutsch M, Zhou W, Rhodes P, et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med. 2004;350(9):896–903.
   PubMed Web of Science ®Google Scholar
• Hambidge SJ, Glanz JM, France EK, et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. Jama J Am Med Assoc. 2006;296(16):1990–1997.
   PubMed Web of Science ®Google Scholar
• Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344(8):564–572.
   PubMed Web of Science ®Google Scholar
• Tseng HF, Liu A, Sy L, et al. Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study. J Intern Med. 2012;271(5):510–520.
   PubMed Web of Science ®Google Scholar
• Mullooly JP, Pearson J, Drew L, et al. Wheezing lower respiratory disease and vaccination of full-term infants. Pharmacoepidemiol Drug Saf. 2002;11(1):21–30.
   PubMed Web of Science ®Google Scholar
• France EK, Glanz J, Xu S, et al. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008;121(3):E687–E692.
   PubMed Web of Science ®Google Scholar
• Kramarz P, DeStefano F, Gargiullo PM, et al. Does influenza vaccination exacerbate asthma?analysis of a large cohort of children with asthma. Arch Family Med. 2000;9(7):617.
   PubMedGoogle Scholar
• Martin T, Fahey M, Easton M, et al. Acute disseminated encephalomyelitis and routine childhood vaccinations–a self-controlled case series. Hum Vaccin Immunother. 2021;17(8):2578–2585.
   PubMed Web of Science ®Google Scholar
• Morgan TM, Schlegel C, Edwards KM, et al. Vaccines are not associated with metabolic events in children with urea cycle disorders. Pediatrics. 2011;127(5):e1147–e1153.
   PubMed Web of Science ®Google Scholar
• Payne DC, Aranas A, McNeil MM, et al. Concurrent vaccinations and US military hospitalizations. Ann Epidemiol. 2007;17(9):697–703.
   PubMed Web of Science ®Google Scholar
• Traversa G, Spila-Alegiani S, Bianchi C, et al. Sudden unexpected deaths and vaccinations during the first two years of life in Italy: a case series study. PLoS One. 2011;6(1):e16363.
   PubMed Web of Science ®Google Scholar
• Wilson K, Duque DR, Murphy MS, et al. T-cell receptor excision circle levels and safety of paediatric immunization: a population-based self-controlled case series analysis. Hum Vaccin Immunother. 2018;14(6):1378–1391.
   PubMed Web of Science ®Google Scholar
• Yung CF, Ma X, Cheung YB, et al. Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children. Sci Rep. 2019;9(1):14705.
   PubMedGoogle Scholar
• Cohet C, Haguinet F, Dos SG, et al. Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series. BMJ Open. 2016;6(1):e009264.
   PubMed Web of Science ®Google Scholar
• Tate JE, Mwenda JM, Armah G, et al. Evaluation of intussusception after monovalent rotavirus vaccination in Africa. N Engl J Med. 2018;378(16):1521–1528.
   PubMed Web of Science ®Google Scholar
• Romio S, Weibel D, Dieleman JP, et al. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. PloS One. 2014;9(1):e82222.
   PubMed Web of Science ®Google Scholar
• Andrews N, Stowe J, Al-Shahi SR, et al. Guillain-Barre syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Vaccine. 2011;29(45):7878–7882.
   PubMed Web of Science ®Google Scholar
• Crawford NW, Cheng A, Andrews N, et al. Guillain-Barre syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series. Med J Aust. 2012;197(10):574–578.
   PubMed Web of Science ®Google Scholar
• Dodd CN, Romio SA, Black S, et al. International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine. 2013;31(40):4448–4458.
   PubMed Web of Science ®Google Scholar
• Quinn HE, Wood NJ, Cannings KL, et al. Intussusception after monovalent human rotavirus vaccine in Australia: severity and comparison of using healthcare database records versus case confirmation to assess risk. Pediatr Infect Dis J. 2014;33(9):959–965.
   PubMed Web of Science ®Google Scholar
• Yung CF, Chan SP, Soh S, et al. Intussusception and monovalent rotavirus vaccination in Singapore: self-Controlled Case Series and Risk-Benefit Study. J Pediatr. 2015;167(1):163–8.e1.
   PubMed Web of Science ®Google Scholar
• Stowe J, Andrews N, Ladhani S, et al. The risk of intussusception following monovalent rotavirus vaccination in England: a self-controlled case-series evaluation. Vaccine. 2016;34(32):3684–3689.
   PubMed Web of Science ®Google Scholar
• INCLEN Intussusception Surveillance Network Study Group, Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: a self-controlled case series analysis. Vaccine. 2021;39(1):78–84.
   PubMed Web of Science ®Google Scholar
• Huang WT, Juan YC, Liu CH, et al. Intussusception and Kawasaki disease after rotavirus vaccination in Taiwanese infants. Vaccine. 2020;38(40):6299–6303.
   PubMed Web of Science ®Google Scholar
• Vannice KS, Modibo K, Sow SO, et al. Active surveillance for adverse events after a mass vaccination campaign with a Group A meningococcal conjugate vaccine (PsA-TT) in Mali. Clinl Infect Dis. 2015;61(suppl 5):S493–500.
   PubMedGoogle Scholar
• Guignard A, Praet N, Jusot V, et al. Introducing new vaccines in low- and middle-income countries: challenges and approaches. Expert Rev Vaccines. 2019;18(2):119–131.
   PubMed Web of Science ®Google Scholar
• Pal SN, Duncombe C, Falzon D, et al. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf. 2013;36(2):75–81.
   PubMed Web of Science ®Google Scholar
• Fletcher AP. Spontaneous adverse drug reaction reporting vs event monitoring: a comparison. J R Soc Med. 1991;84(6):341–344.
   PubMed Web of Science ®Google Scholar
• Crawford NW, Clothier H, Hodgson K, et al. Active surveillance for adverse events following immunization. Expert Rev Vaccines. 2014;13(2):265–276.
   PubMed Web of Science ®Google Scholar
• Liu Z, Meng R, Yang Y, et al. Active vaccine safety surveillance: global trends and challenges in China. Health Data Sci. 2021;2021:1–10 DOI:https://doi.org/10.34133/2021/9851067.
   Google Scholar
• Reddy S, Nair NP, Giri S, et al. Safety monitoring of ROTAVAC vaccine and etiological investigation of intussusception in India: study protocol. BMC Public Health. 2018;18(1):898.
   PubMedGoogle Scholar
• Simpson SE. A positive event dependence model for self-controlled case series with applications in postmarketing surveillance. Biometrics. 2013;69(1):128–136.
   PubMed Web of Science ®Google Scholar
• Whitaker HJ, Ghebremichael-Weldeselassie Y. Self-controlled case series methodology. Annu Rev Stat Appl. 2019;6(1):241–261.
   Google Scholar
• Whitaker HJ, Farrington CP, Spiessens B, et al. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25(10):1768–1797.
   PubMed Web of Science ®Google Scholar
• Farrington CP, Whitaker HJ. Semiparametric analysis of case series data. Appl Stat. 2006;55(Part 5):553–594.
   Google Scholar
• Farrington CP, Whitaker HJ, Hocine MN. Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics. 2009;10(1):3–16.
   PubMed Web of Science ®Google Scholar
• Ghebremichael-Weldeselassie Y, Whitaker HJ, Farrington CP. Self-controlled case series method with smooth age effect. Stat Med. 2014;33(4):639–649.
   PubMed Web of Science ®Google Scholar